Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among
reproductive-aged women. It is characterized by chronic anovulation, hyperandrogenism …

Objective To compare between different combined oral contraceptive pills (COCPs) as part
of the update of the International Evidence-Based Guidelines on the Assessment and …

Context: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting
women of reproductive age. Hyperandrogenism is the central feature of PCOS. Studies on …

Context Polycystic ovary syndrome (PCOS) affects more than 1 in 10 women. Objective As
part of the 2023 International PCOS Guidelines update, comparisons between combined …

Polycystic ovary syndrome (PCOS) is the most common cause of chronic anovulation and
hyperandrogenism in young women. Excessive ovarian production of Anti-Müllerian …

Background Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine and
metabolic disorder among reproductive aged women, leading to infertility. One of the …

OBJECTIVE: To compare the effects of continuous use of oral (OC), transdermal, and
vaginal combined contraceptives on the pituitary-ovarian axis and inhibition of follicular …

Objective The study aims to address whether serum anti-müllerian hormone (AMH) levels
fluctuate in the short term after medication application, including oral contraceptives (OCs) …

Background Metformin has been proposed as possibly a safer and more effective long‐term
treatment than the oral contraceptive pill (OCP) in women with polycystic ovary syndrome …

Abstract Background Although oral contraceptives (OCs) are the most common treatment in
women with polycystic ovary syndrome (PCOS), their effects and safety on the metabolic …